Why This Massachusetts Synthetic Bio Startup Could be the Next Biotech Unicorn Post author:Sam Post published:December 11, 2017 Post category:BioPharma In investment jargon, a “unicorn” has at least two meanings. Source: BioSpace You Might Also Like Bay Area Rigel's CFO to Exit, Effective Dec. 31, 2017 December 14, 2017 Nestle Emerges as the Frontrunner for Merck KGaA's $5B Consumer Health Biz January 9, 2018 Symcel: Calorimetry-Based 3D Phenotype Assays: A Necessity For Drug Discovery And Personalized Medicine June 18, 2017
Symcel: Calorimetry-Based 3D Phenotype Assays: A Necessity For Drug Discovery And Personalized Medicine June 18, 2017
